InFo Onkologie

, Volume 21, Issue 3, pp 12–13 | Cite as

Remissionsbeurteilung beim multiplen Myelom

Stellenwert von MRD-Status und Bildgebung

journal club


  1. 1.
    Moreau P et al. J Clin Oncol. 2017;35(25):2911–18.CrossRefGoogle Scholar
  2. 2.
    Avet-Loiseau H et al. Blood. 2017;130(Suppl 1):435.Google Scholar
  3. 3.
    Rasche L et al. Nat Commun. 2017;8(1):268.CrossRefGoogle Scholar
  4. 4.
    Schinke C et al. Haematologica. 2017;102(8):e313–e316.CrossRefGoogle Scholar
  5. 5.
    Rasche L et al. Blood. 2017;130(1):30–4.CrossRefGoogle Scholar


  1. Moreau P et al. Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study. J Clin Oncol. 2017; 35(25):2911–18.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.UAMS Myeloma InstituteUniversity of Arkansas for Medical ScienceLittle RockUSA

Personalised recommendations